Healthcare | October 09, 2025
WHO and OneSight EssilorLuxottica partner to expand vision care in Karnataka
WHO’s global SPECS 2030 target to increase effective refractive error coverage by 40% by 2030
WHO’s global SPECS 2030 target to increase effective refractive error coverage by 40% by 2030
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
Lilly's Omvoh is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis
RedHill will receive $500,000 in guaranteed payments, including a $250,000 upfront payment and $250,000 in fixed payments due within 18 months
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
New study presents a human-relevant stress model for assessing potential therapeutics
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Datroway becomes the first and only therapy to show overall survival benefit versus chemotherapy in this difficult-to-treat patient population
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
Medico Remedies receives order worth US$ 1,781,000
Subscribe To Our Newsletter & Stay Updated
